138 related articles for article (PubMed ID: 28819401)
1. Identification and validation of soluble carrier family expression signature for predicting poor outcome of renal cell carcinoma.
Fangning W; Chunguang M; Hailiang Z; Guohai S; Yao Z; Bo D; Yijun S; Yiping Z; Dingwei Y
J Cancer; 2017; 8(11):2010-2017. PubMed ID: 28819401
[TBL] [Abstract][Full Text] [Related]
2. ITGA2B and ITGA8 are predictive of prognosis in clear cell renal cell carcinoma patients.
Lu X; Wan F; Zhang H; Shi G; Ye D
Tumour Biol; 2016 Jan; 37(1):253-62. PubMed ID: 26198048
[TBL] [Abstract][Full Text] [Related]
3. NUDT expression is predictive of prognosis in patients with clear cell renal cell carcinoma.
Wang Y; Wan F; Chang K; Lu X; Dai B; Ye D
Oncol Lett; 2017 Nov; 14(5):6121-6128. PubMed ID: 29113256
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of D-lactate dehydrogenase in patients with clear cell renal cell carcinoma.
Wang Y; Li G; Wan F; Dai B; Ye D
Oncol Lett; 2018 Jul; 16(1):866-874. PubMed ID: 29963157
[TBL] [Abstract][Full Text] [Related]
5. Prognostic implications of Aquaporin 9 expression in clear cell renal cell carcinoma.
Xu WH; Shi SN; Xu Y; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
J Transl Med; 2019 Nov; 17(1):363. PubMed ID: 31703694
[TBL] [Abstract][Full Text] [Related]
6. The SLC Family Are Candidate Diagnostic and Prognostic Biomarkers in Clear Cell Renal Cell Carcinoma.
Kang W; Zhang M; Wang Q; Gu D; Huang Z; Wang H; Xiang Y; Xia Q; Cui Z; Jin X
Biomed Res Int; 2020; 2020():1932948. PubMed ID: 32461965
[TBL] [Abstract][Full Text] [Related]
7. Construction and Validation of an Autophagy-Related Prognostic Risk Signature for Survival Predicting in Clear Cell Renal Cell Carcinoma Patients.
Yang H; Han M; Li H
Front Oncol; 2020; 10():707. PubMed ID: 32432045
[No Abstract] [Full Text] [Related]
8. The Role of Serine Peptidase Inhibitor Kazal Type 13 (SPINK13) as a Clinicopathological and Prognostic Biomarker in Patients with Clear Cell Renal Cell Carcinoma.
Xu WH; Shi SN; Wang J; Xu Y; Tian X; Wan FN; Cao DL; Qu YY; Zhang HL; Ye DW
Med Sci Monit; 2019 Dec; 25():9458-9470. PubMed ID: 31825950
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of COL6A1 is predictive of poor prognosis in clear cell renal cell carcinoma patients.
Wan F; Wang H; Shen Y; Zhang H; Shi G; Zhu Y; Dai B; Ye D
Oncotarget; 2015 Sep; 6(29):27378-87. PubMed ID: 26317545
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma.
Qu L; Wang ZL; Chen Q; Li YM; He HW; Hsieh JJ; Xue S; Wu ZJ; Liu B; Tang H; Xu XF; Xu F; Wang J; Bao Y; Wang AB; Wang D; Yi XM; Zhou ZK; Shi CJ; Zhong K; Sheng ZC; Zhou YL; Jiang J; Chu XY; He J; Ge JP; Zhang ZY; Zhou WQ; Chen C; Yang JH; Sun YH; Wang LH
Eur Urol; 2018 Dec; 74(6):756-763. PubMed ID: 30143382
[TBL] [Abstract][Full Text] [Related]
11. Construction and Validation of a 9-Gene Signature for Predicting Prognosis in Stage III Clear Cell Renal Cell Carcinoma.
Wu J; Jin S; Gu W; Wan F; Zhang H; Shi G; Qu Y; Ye D
Front Oncol; 2019; 9():152. PubMed ID: 30941304
[No Abstract] [Full Text] [Related]
12. Diagnostic and prognostic value of CEP55 in clear cell renal cell carcinoma as determined by bioinformatics analysis.
Zhou L; Liu S; Li X; Yin M; Li S; Long H
Mol Med Rep; 2019 May; 19(5):3485-3496. PubMed ID: 30896867
[TBL] [Abstract][Full Text] [Related]
13. Identification of a three-miRNA signature as a novel potential prognostic biomarker in patients with clear cell renal cell carcinoma.
Luo Y; Chen L; Wang G; Xiao Y; Ju L; Wang X
J Cell Biochem; 2019 Aug; 120(8):13751-13764. PubMed ID: 30957284
[TBL] [Abstract][Full Text] [Related]
14. Fatty Acid Synthase Correlates With Prognosis-Related Abdominal Adipose Distribution and Metabolic Disorders of Clear Cell Renal Cell Carcinoma.
Xu W; Hu X; Anwaier A; Wang J; Liu W; Tian X; Zhu W; Ma C; Wan F; Shi G; Qu YY; Zhang H; Ye D
Front Mol Biosci; 2020; 7():610229. PubMed ID: 33569391
[No Abstract] [Full Text] [Related]
15. A Novel Radiogenomics Biomarker Based on Hypoxic-Gene Subset: Accurate Survival and Prognostic Prediction of Renal Clear Cell Carcinoma.
Gao J; Ye F; Han F; Wang X; Jiang H; Zhang J
Front Oncol; 2021; 11():739815. PubMed ID: 34692518
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive analysis of a novel lncRNA profile reveals potential prognostic biomarkers in clear cell renal cell carcinoma.
Liu T; Sui J; Zhang Y; Zhang XM; Wu WJ; Yang S; Xu SY; Hong WW; Peng H; Yin LH; Pu YP; Liang GY
Oncol Rep; 2018 Sep; 40(3):1503-1514. PubMed ID: 30015930
[TBL] [Abstract][Full Text] [Related]
17. SOX2 and SOX12 are predictive of prognosis in patients with clear cell renal cell carcinoma.
Gu W; Wang B; Wan F; Wu J; Lu X; Wang H; Zhu Y; Zhang H; Shi G; Dai B; Ye D
Oncol Lett; 2018 Apr; 15(4):4564-4570. PubMed ID: 29541226
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of FZD1 is Associated with a Good Prognosis and Resistance of Sunitinib in Clear Cell Renal Cell Carcinoma.
Peng Q; Wang L; Zhao D; Lv Y; Wang H; Chen G; Wang J; Xu W
J Cancer; 2019; 10(5):1237-1251. PubMed ID: 30854133
[TBL] [Abstract][Full Text] [Related]
19. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway.
Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W
Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137
[TBL] [Abstract][Full Text] [Related]
20. A Panel of Four-lncRNA Signature as a Potential Biomarker for Predicting Survival in Clear Cell Renal Cell Carcinoma.
Liu H; Ye T; Yang X; Lv P; Wu X; Zhou H; Zeng J; Tang K; Ye Z
J Cancer; 2020; 11(14):4274-4283. PubMed ID: 32368310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
